Metabolic Profile Reveals the Immunosuppressive Mechanisms of Methionyl-Methionine in Lipopolysaccharide-Induced Inflammation in Bovine Mammary Epithelial Cell

Our previous transcriptomic study found that methionyl-methionine (Met-Met) exerts an anti-inflammatory effect in the bovine mammary epithelial cell (MAC-T) at a molecular level. However, evidence of whether the metabolic production of Met-Met confers protection was scarce. To investigate the inflam...

Full description

Bibliographic Details
Main Authors:	Wei Lan, Yifei Ren, Zhen Wang, Jianxin Liu, Hongyun Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Animals
Subjects:	Met-Met lipopolysaccharide inflammation MAC-T
Online Access:	https://www.mdpi.com/2076-2615/11/3/833

Similar Items

DL-Methionyl–DL-Methionine/DL-Methionine Supplementation Alleviated the Adverse Effects of Dietary Low Fishmeal Levels on Growth and Intestinal Health of <i>Micropterus salmoides</i>
by: Heng Yu, et al.
Published: (2024-03-01)

D-Methionine and 2-hydroxy-4-methylthiobutanoic acid i alter beta-casein, proteins and metabolites linked in milk protein synthesis in bovine mammary epithelial cells
by: Seung-Woo Jeon, et al.
Published: (2022-05-01)

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
by: Gianluca Spitaleri, et al.
Published: (2023-09-01)

Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer
by: Yaolin Song, et al.
Published: (2021-09-01)

A kinetic and mechanistic study on the oxidation of l-methionine and N-acetyl l-methionine by cerium(IV) in sulfuric acid medium
by: T. Sumathi, et al.
Published: (2016-09-01)

Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
by: Ningning Yan, et al.
Published: (2023-05-01)

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
by: Ningning Yan, et al.
Published: (2023-07-01)

Mesenchymal–Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis
by: Francisco Cezar Aquino de Moraes, et al.
Published: (2023-12-01)

The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis
by: Rawnaq Esa, et al.
Published: (2020-07-01)

Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trialResearch in context
by: Yongfeng Yu, et al.
Published: (2023-05-01)

FgMet3 and FgMet14 related to cysteine and methionine biosynthesis regulate vegetative growth, sexual reproduction, pathogenicity, and sensitivity to fungicides in Fusarium graminearum
by: Feifei Zhao, et al.
Published: (2022-10-01)

Adenylyl-Sulfate Kinase (Met14)-Dependent Cysteine and Methionine Biosynthesis Pathways Contribute Distinctively to Pathobiological Processes in Cryptococcus neoformans
by: Seung-Heon Lee, et al.
Published: (2023-06-01)

Measurement of the Zγ→νν‾γ production cross section in pp collisions at s=8 TeV and limits on anomalous ZZγ and Zγγ trilinear gauge boson couplings
by: V. Khachatryan, et al.
Published: (2016-09-01)

The German Priority Program SPP 1276 “Multiple Scales in Fluid Mechanics and Meteorology” (MetStröm)
by: Rupert Klein, et al.
Published: (2014-09-01)

MET fusions are targetable genomic variants in the treatment of advanced malignancies
by: Dantong Sun, et al.
Published: (2024-01-01)

Clinical and paraclinical characteristics of metabolic syndrome in children with overweight and obesity in Dong Nai province, Vietnam
by: Ha Van Thieu
Published: (2022-04-01)

Effects of Peptidoglycan, Lipoteichoic Acid and Lipopolysaccharide on Inflammation, Proliferation and Milk Fat Synthesis in Bovine Mammary Epithelial Cells
by: Yongjiang Wu, et al.
Published: (2020-08-01)

Overview of Molecular Detection Technologies for <i>MET</i> in Lung Cancer
by: Carina Heydt, et al.
Published: (2023-05-01)

Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature
by: Daniel S Lefler, et al.
Published: (2022-12-01)

Research Progresses in the Treatment of NSCLC with MET Gene Variants: A Riview
by: Ran CHEN, et al.
Published: (2022-12-01)

Padrão de atividade física entre gestantes atendidas pela estratégia saúde da família de Campina Grande - PB Physical activity patterns in pregnant women attending the family health program of Campina Grande - PB
by: Jousilene de Sales Tavares, et al.
Published: (2009-03-01)

Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis
by: Shelly C. Lu, et al.
Published: (2011-03-01)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
by: Jian Lu, et al.
Published: (2023-10-01)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
by: Nichola Cruickshanks, et al.
Published: (2017-07-01)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with <i>MET</i> Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
by: Wei Yin, et al.
Published: (2022-05-01)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
by: Chiara Modica, et al.
Published: (2020-03-01)

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
by: Philippe Rochigneux, et al.
Published: (2018-11-01)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
by: Jan Trøst Jørgensen, et al.
Published: (2022-04-01)

Paracrine Met signaling triggers epithelial–mesenchymal transition in mammary luminal progenitors, affecting their fate
by: Amandine Di-Cicco, et al.
Published: (2015-07-01)

Effects of dietary methionine supplementation on the growth performance, immune responses, antioxidant capacity, and subsequent development of layer chicks
by: Jiatu Zhang, et al.
Published: (2024-03-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
by: Sally C.M. Lau, MD, MPH, et al.
Published: (2023-10-01)

Inhibition of Mycelial Growth by Methotrexate in Neurospora crassa Wild Type and Mutants Deficient in Folylpolyglutamate Synthase
by: Wrishko Rebecca E., et al.
Published: (1998-11-01)

The role of epithelial–mesenchymal transition (EMT)-associated genes during gonadogenesis of albino rat
by: Lina A. Aeshra, et al.
Published: (2020-01-01)

The in vitro effect of lipopolysaccharide on proliferation, inflammatory factors and antioxidant enzyme activity in bovine mammary epithelial cells
by: Huiyu Shi, et al.
Published: (2016-06-01)

Molecular characterization of MET fusions from a large real‐world Chinese population: A multicenter study
by: Hui Xia, et al.
Published: (2023-07-01)

Targeting <i>MET</i> Amplification: Opportunities and Obstacles in Therapeutic Approaches
by: Yuichi Kumaki, et al.
Published: (2023-09-01)

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation
by: Shinkichi Takamori, et al.
Published: (2021-03-01)

Zng1 is a GTP-dependent zinc transferase needed for activation of methionine aminopeptidase
by: Miriam Pasquini, et al.
Published: (2022-05-01)

Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer
by: Federico Bocci, et al.
Published: (2022-06-01)